Clinical trial Recruiting at 1 site Interventional Ages 18 to 70

Iliac crest marrow versus proximal tibia Avitus bone graft for foot and ankle procedures

Official title: Comparison of Iliac Crest Marrow vs. Proximal Tibia Avitus® Bone Graft

Run by Mayo Clinic · NCT07434505 · Data updated 2026-11-12

This will test whether bone graft taken from the proximal tibia with the Avitus device works as well as iliac crest bone marrow for adults needing autograft during foot or ankle fusion or nonunion surgery.

More Bone Graft trials

Quick facts

Study typeInterventional
Ages18 Years to 70 Years
SexAll
Enrollment12 (estimated)
SponsorMayo Clinic
Academic / other
Drugs / interventionschemotherapy, radiation
Locations1 site (Jacksonville, Florida)
StatusRecruiting
StartedNovember 6, 2025
Main results expectedDecember 2026
Study endsDecember 2026
Registry record updatedFebruary 25, 2026
Trial IDNCT07434505 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–69 who are skeletally mature, speak English or have a translator, and are scheduled for indicated foot or ankle fusion or nonunion surgery with an indication for both proximal tibia autograft and iliac crest bone marrow aspiration and sufficient harvest volume are ideal candidates.

Probably not a fit

Patients aged 70 or older, those with osteopenia/osteoporosis, prior bilateral iliac wing trauma or bilateral total knee arthroplasties, insufficient harvest volume, or who are not undergoing the specified procedures are unlikely to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults scheduled for ankle, hindfoot, or complex mid/forefoot fusion or treatment of nonunions who require autograft will be enrolled at Mayo Clinic Jacksonville. Each participant will have marrow or graft material obtained from the iliac crest and from the proximal tibia using the Avitus Bone Harvester so comparative samples can be collected. Samples will be compared for harvest volume and cellular/material properties, and patients will be followed for immediate procedural outcomes and donor-site morbidity. Preoperative radiographs of the knee and pelvis will confirm suitability of harvest sites.

Why it matters

Potential benefit: If successful, the Avitus proximal tibia harvest could provide similar graft material with less donor-site pain and fewer complications than traditional iliac crest harvest.

How similar studies have gone: Prior reports suggest proximal tibia harvest can yield comparable cell counts to iliac crest marrow in some settings, but device-specific head-to-head data for the Avitus harvester are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patient must be 18 years of age or older.
* Patient must be able and willing to sign the IRB approved informed consent.
* Patient must consent to preoperative knee and pelvis radiographs to confirm no issue at harvest location.
* Patient has indication for autograft bone harvest (undergoing any ankle or hindfoot fusion, complex mid and forefoot fusions requiring graft supplementation, treatment of fuse and fracture nonunions)
* Patient is indicated for proximal tibia autograft harvest and iliac crest BMA (e.g. no hx bilateral TKAs or previous iliac wing trauma bilaterally).
* Patient is skeletally "mature" and presents with no concern for osteopenia/osteoporosis.
* Patient has sufficient volume of harvest material for study inclusion (minimum of 10 ml of cancellous bone graft plus 10 ml fluid pressed out from cancellous bone portion)
* Patient must speak English or have access to sufficient translator.

Exclusion Criteria:

* Patient is 70 yrs of age or older.
* Patient is unwilling or unable to give consent or comply with study protocol.
* Patient has any condition, which in the judgement of the Investigator, places the patient at undue risk or interferes with the study.
* Patient has mental or neurological disorder that will not allow for proper informed consent.
* Patient is known to be pregnant or breastfeeding.
* Patient is a vulnerable subject (prisoner, mentally incompetent or unable to understand what participation to the study entails, a known alcohol or drug abuser, and/or anticipated to be non-compliant).
* Patient has any condition, which in the judgement of the Investigator, may chemically skew bone marrow. This may include but is not limited to the following:

  * Cancer
  * Undergoing chemotherapy radiation,
  * Bone marrow transplant
  * Infection at the donor sites
  * Organ transplant on antirejection meds
  * Usage of anti-rheumatologic drugs
  * Chronic steroid usage
  * Anemia
  * Myelodysplastic Syndromes
* Patient presents with arthritis of the knee and may require knee replacement within the next 12 months.

Where it's running

  • Mayo Clinic
    Jacksonville, Florida, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.